Skip to content

DName-iT: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DName-iT

BE 0506.754.823
NACE 86.910, Medical imaging and medical laboratories
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€74,453
2024 · -€41,225-€33,228
Equity
€110,253
2024 · €184,706-€74,453
Cash
€11,233
2024 · €1,572+€9,661
Balance sheet total
€512,454
2024 · €504,581+€7,873

Largest movements

2024 to 2025
Assets
  • Cash +€9,661

    up €9,661 (+614.6%), from €1,572 to €11,233

    mainly Trade debts (+€53,452) and Other debts (+€26,500)

Equity and liabilities
  • Profit (loss) carried forward -€74,453

    down €74,453 (-6.7%), from -€1.1m to -€1.2m

  • Trade debts +€53,452

    up €53,452 (+1270.1%), from €4,208 to €57,660

  • Other debts +€26,500

    up €26,500 (+27.9%), from €95,000 to €121,500

Income statement
  • Gross operating margin -€33,104

    down €33,104 (-86.4%), from -€38,327 to -€71,430

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€41,225
Gross operating margin -€33,104
Other operating charges +€150
Financial charges -€274
Result 2025 -€74,453

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€9,761
Investment -€100
Financing €0
Cash 2024 €1,572
Net result for the year -€74,453
Receivables within one year +€2,261
Deferred charges and accrued income -€373
Trade debts +€53,452
Other debts +€26,500
Accrued charges and deferred income +€2,374
Investment in fixed assets (net) -€100
Cash 2025 €11,233
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €504,581 €512,454 +€7,873 +1.6%
Fixed assets 21/28 €500,000 €500,100 +€100 0.0%
Intangible fixed assets 21 €500,000 €500,000 = 0.0%
Financial fixed assets 28 - €100 +€100
Current assets 29/58 €4,581 €12,354 +€7,773 +169.7%
Amounts receivable within one year 40/41 €3,009 €748 -€2,261 -75.1%
Other amounts receivable 41 €3,009 €748 -€2,261 -75.1%
Cash at bank and in hand 54/58 €1,572 €11,233 +€9,661 +614.6%
Deferred charges and accrued income 490/1 - €373 +€373
Total equity and liabilities 10/49 €504,581 €512,454 +€7,873 +1.6%
Equity 10/15 €184,706 €110,253 -€74,453 -40.3%
Contributions 10/11 €1,300,000 €1,300,000 = 0.0%
Capital 10 €1,300,000 €1,300,000 = 0.0%
Issued capital 100 €1,300,000 €1,300,000 = 0.0%
Profit (loss) carried forward 14 -€1,115,294 -€1,189,747 -€74,453 -6.7%
Amounts payable 17/49 €319,875 €402,201 +€82,326 +25.7%
Amounts payable within one year 42/48 €316,208 €396,160 +€79,952 +25.3%
Current portion of amounts payable after more than one year 42 €217,000 €217,000 = 0.0%
Trade debts 44 €4,208 €57,660 +€53,452 +1270.1%
Suppliers 440/4 €4,208 €57,660 +€53,452 +1270.1%
Other amounts payable 47/48 €95,000 €121,500 +€26,500 +27.9%
Accrued charges and deferred income 492/3 €3,667 €6,041 +€2,374 +64.8%
Other operating charges 640/8 €637 €487 -€150 -23.5%
Gross operating margin 9900 -€38,327 -€71,430 -€33,104 -86.4%
Operating profit (loss) 9901 -€38,964 -€71,918 -€32,954 -84.6%
Financial charges 65/66B €2,261 €2,535 +€274 +12.1%
Recurring financial charges 65 €2,261 €2,535 +€274 +12.1%
Profit (loss) for the period before taxes 9903 -€41,225 -€74,453 -€33,228 -80.6%
Profit (loss) for the period 9904 -€41,225 -€74,453 -€33,228 -80.6%
Profit (loss) for the period to be appropriated 9905 -€41,225 -€74,453 -€33,228 -80.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.